SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-16-011225
Filing Date
2016-02-25
Accepted
2016-02-25 18:51:56
Documents
1
Period of Report
2016-02-25

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3022516krafte_icageninc.html 3  
1 OWNERSHIP DOCUMENT f3022516krafte_icageninc.xml 3 1532
  Complete submission text file 0001213900-16-011225.txt   3183
Mailing Address ONE KENDALL SQUARE, BUILDING 200 SUITE 2 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE, BUILDING 200 SUITE 2 CAMBRIDGE MA 02139 617-631-8825
Icagen, Inc. (Issuer) CIK: 0001518520 (see all company filings)

IRS No.: 200982060 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services

Mailing Address C/O 4222 EMPEROR BLVD, SUITE 350 RESEARCH TRIANGLE PARK DURHAM NC 27703
Business Address
Krafte Douglas (Reporting) CIK: 0001667759 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54748 | Film No.: 161457415